10-yr follow-up retention
96%
T2D risk reduction (per 10% VAT loss)
~30%
Visceral fat depots
Partially preserved
Liver & pancreatic fat
Fully regained
3 New Papers: Lose Visceral Fat Once and It Pays Off for a Decade, Resistance Training's Mortality Sweet Spot, and Exercise as Sleep Medicine
Three PubMed papers indexed May 27–June 3, 2026: a 10-year MRI follow-up of two RCTs (n=366) shows visceral fat loss durably cuts T2D risk by ~30% even after full weight regain; a 147,374-person 30-year cohort study finds 90–119 min/week of resistance training cuts all-cause mortality 13% and CVD mortality 19%, with no extra benefit above 120 min/week; and a 32-person 16-week RCT shows multimodal exercise cuts waking-after-sleep-onset by 33 minutes in older adults, measured by actigraphy.
リサーチノート
June 3, 2026 · Nutrition / Exercise Science / Sleep Research
Nutrition: Losing Visceral Fat — Even Briefly — Protects Your Metabolism for Years
The finding in plain terms. Diet and exercise interventions that shrink visceral fat produce lasting cardiometabolic benefits — even after all the lost weight comes back. A new 10-year MRI follow-up published in Circulation tracked 366 of the original 381 participants (96%) from two landmark Israeli randomized controlled trials — CENTRAL and DIRECT-PLUS — which compared low-fat, Mediterranean, and polyphenol-enriched "Green Mediterranean" diets combined with structured physical activity over 18 months. 1
What the MRI data showed. Participants fully regained their body weight by the 5- and 10-year follow-up visits. Yet despite complete weight regain, abdominal fat depots — visceral adipose tissue, deep subcutaneous fat, and superficial subcutaneous fat — partially retained their intervention-induced reductions (false discovery rate ≤0.01 for all). The liver and pancreas told a different story: intrahepatic fat and intrapancreatic fat were fully — and in the case of pancreatic fat, excessively — regained, tracking closely with weight.
The metabolic math. Using meta-analysis models adjusted for weight change, Mediterranean diet adherence, and physical activity at follow-up, the researchers found that each 10% reduction in visceral fat achieved during the trial was associated with measurable long-term improvements in insulin resistance, a composite cardiometabolic risk score, and Metabolic Syndrome Severity Score. Translating that: a 10% visceral fat loss from lifestyle change may reduce future type 2 diabetes risk by approximately 30%, even after the scale goes back up. 1
統計カードを読み込んでいます…
Study details. Design: follow-up of 2 RCTs (CENTRAL, NCT01530724; DIRECT-PLUS, NCT03020186) conducted 2012–2018. n=366 (62% male). MRI measured five fat compartments at multiple time points. No conflicts of interest declared.
Actionable takeaway. Visceral fat — not scale weight — is the more important target. A Mediterranean or Green-Mediterranean diet combined with structured physical activity that shrinks your waistline even once can leave a lasting biological imprint on your metabolic risk, regardless of what happens to total weight afterward. If a diet phase helps you lose visceral fat, the cardiometabolic payoff may persist for years; don't write it off as a failure because the weight returned.
COI disclosure: None declared.
Exercise Science: The Resistance Training Dose That Maximizes Lifespan
The finding in plain terms. Two to two-and-a-half hours of resistance training per week — roughly 90–119 minutes — appears to be the dose sweet spot for lowering long-term mortality, and combining it with adequate aerobic activity compounds the benefit. A large prospective analysis published in the British Journal of Sports Medicine pooled data from 147,374 adults across three U.S. cohorts followed for up to 30 years. 2
The dose-response curve. Compared with no resistance training, 90–119 min/week was associated with:
| Outcome | Hazard Ratio (95% CI) | Risk Reduction |
|---|---|---|
| All-cause mortality | 0.87 (0.81–0.95) | −13% |
| Cardiovascular mortality | 0.81 (0.67–0.97) | −19% |
| Neurological disease mortality | 0.73 (0.58–0.92) | −27% |
Critically, no additional mortality benefit appeared above 120 min/week for all-cause or cardiovascular outcomes. Cancer mortality showed a different profile: benefit was observed only at lower doses (1–29 min/week: HR 0.91; 30–59 min/week: HR 0.88), with the protective signal attenuating at higher volumes.
統計カードを読み込んでいます…
The aerobic combination effect. In joint analyses, participants who met aerobic physical activity guidelines (≥7.5 MET-hours/week) and did 90–119 min/week of resistance training had the largest mortality risk reductions. Neither mode fully replaced the other's benefit.
Study details. Design: three prospective cohort studies — Health Professionals Follow-up Study (1992–2022), Nurses' Health Study (2002–2021), Nurses' Health Study II (2003–2021). Resistance training and aerobic duration assessed biennially via validated questionnaire. Cox models adjusted for multiple confounders. n=147,374; 35,798 deaths documented. No conflicts of interest declared. 2
Actionable takeaway. If you're already doing aerobic exercise, adding ~100 minutes of resistance training per week — two reasonably full lifting sessions — produces meaningful, quantifiable mortality reductions. More than 2 hours doesn't appear to add further longevity benefit for most people; the sweet spot is narrow. Cancer prevention may even favor shorter, more frequent resistance sessions over long ones.
COI disclosure: None declared.
Sleep Research: Multimodal Exercise Measurably Rewires Sleep in Older Adults
The finding in plain terms. A 16-week program of supervised multimodal exercise — combining aerobic, resistance, balance, and flexibility training — significantly improved objective sleep quality in older adults, cutting the time spent awake after falling asleep by more than half an hour per night. The improvements were measured with wrist actigraphy, not self-report questionnaires, making the data more rigorous than most behavioral sleep studies. 3
What the actigraphy showed. Thirty-two adults aged 70.1 ± 5.7 years were randomized 2:1 to multimodal exercise (n≈21) or a control group. Progressive sessions ran 3× per week, 45–60 minutes each. After 16 weeks, between-group comparisons showed:
- Sleep efficiency: +6.6 percentage points (95% CI: 1.8–11.4) — exercise group vs. control
- Wake after sleep onset (WASO): −33.2 minutes (95% CI: −65.9 to −0.5) — a large reduction in nighttime wakefulness
- Sleep fragmentation index: −8.0 (95% CI: −15.6 to −0.6)
- Sleep latency: −3.4 minutes within the exercise group (95% CI: −6.6 to −0.2), a significant within-group improvement
Adherence was 90%, and all assessments were conducted by a blinded evaluator.
Study details. Design: parallel-group RCT, 2:1 randomization stratified by sex and age. Sleep assessed by actigraphy for 7 consecutive days at baseline and post-intervention. Published May 30, 2026, in Brazilian Journal of Physical Therapy. No conflicts of interest declared. 3
Limitation to note. The sample is small (n=32), which limits statistical power and generalizability. Replication in larger cohorts is needed.
Actionable takeaway. If poor sleep efficiency or frequent nighttime awakenings are a concern — especially for adults over 65 — a structured multi-modal exercise program three days per week appears to be a clinically meaningful intervention. The 33-minute reduction in WASO is comparable in magnitude to effects seen with some pharmacological sleep aids, without side effects. The key is multimodal variety (not just walking) and progressive load over at least 12–16 weeks.
COI disclosure: None declared.
All three papers indexed on PubMed May 27–June 3, 2026. Studies are peer-reviewed. Summaries reflect abstract-level data; full-text details may add nuance.
このコンテンツについて、さらに観点や背景を補足しましょう。